• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Definitive Healthcare Corp.

    5/14/26 4:18:37 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology
    Get the next $DH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 3)


    Definitive Healthcare Corp.

    (Name of Issuer)


    Class A Common Stock, $0.001 par value

    (Title of Class of Securities)




    24477E103

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    24477E103


    1Names of Reporting Persons

    Advent International, L.P.
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    62,493,676.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    62,493,676.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    62,493,676.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    59.82 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  The reported percentage is calculated based on 104,472,371 shares of Class A common stock ("Common Stock") outstanding as of February 23, 2026, as reported on the Issuer's 10-K filed with the Securities and Exchange Commission ("SEC") on February 26, 2026.


    SCHEDULE 13G

    CUSIP Number(s):
    24477E103


    1Names of Reporting Persons

    Advent International GP, LLC
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    DELAWARE
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    62,493,676.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    62,493,676.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    62,493,676.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    59.82 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  The reported percentage is calculated based on 104,472,371 shares of Common Stock outstanding as of February 23, 2026, as reported on the Issuer's 10-K filed with the SEC on February 26, 2026.


    SCHEDULE 13G

    CUSIP Number(s):
    24477E103


    1Names of Reporting Persons

    Advent International GPE IX Limited Partnership
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    16,955,510.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    16,955,510.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    16,955,510.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    16.23 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  The reported percentage is calculated based on 104,472,371 shares of Common Stock outstanding as of February 23, 2026, as reported on the Issuer's 10-K filed with the SEC on February 26, 2026.


    SCHEDULE 13G

    CUSIP Number(s):
    24477E103


    1Names of Reporting Persons

    Advent International GPE IX-H Limited Partnership
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    CAYMAN ISLANDS
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    5,428,915.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    5,428,915.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    5,428,915.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    5.20 %
    12Type of Reporting Person (See Instructions)

    PN

    Comment for Type of Reporting Person:  The reported percentage is calculated based on 104,472,371 shares of Common Stock outstanding as of February 23, 2026, as reported on the Issuer's 10-K filed with the SEC on February 26, 2026.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Definitive Healthcare Corp.
    (b)Address of issuer's principal executive offices:

    492 Old Connecticut Path, Suite 401, Framingham, MA 01701
    Item 2. 
    (a)Name of person filing:

    This statement is being jointly filed by each of the persons below pursuant to Rule 13d-1(k) promulgated by the SEC pursuant to Section 13 of the Act, all of whom together are referred to herein as the "Reporting Persons": (i) Advent International, L.P., a Delaware limited partnership; (ii) Advent International GP, LLC, a Delaware limited liability company; (iii) Advent International GPE IX Limited Partnership, a Cayman Islands limited partnership; and (iv) Advent International GPE IX-H Limited Partnership, a Cayman Islands limited partnership;
    (b)Address or principal business office or, if none, residence:

    Prudential Tower, 800 Boylston Street, Boston, MA 02199
    (c)Citizenship:

    See responses to row 4 on each cover page.
    (d)Title of class of securities:

    Class A Common Stock, $0.001 par value
    (e)CUSIP No.:

    24477E103
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See responses to row 9 on each cover page. The reported securities are directly held by the following: (i) 16,955,510 shares of Class A common stock held by Advent International GPE IX Limited Partnership; (ii) 3,359,809 shares of Class A common stock held by Advent International GPE IX-B Limited Partnership; (iii) 1,394,766 shares of Class A common stock held by Advent International GPE IX-C Limited Partnership; (iv) 1,463,380 shares of Class A common stock held by Advent International GPE IX-F Limited Partnership; (v) 4,815,226 shares of Class A common stock held by Advent International GPE IX-G Limited Partnership; (vi) 5,428,915 shares of Class A common stock held by Advent International GPE IX-H Limited Partnership; (vii) 3,075,053 shares of Class A common stock held by Advent International GPE IX-I Limited Partnership; (viii) 4,985,850 shares of Class A common stock held by Advent International GPE IX-A SCSP; (ix) 1,061,241 shares of Class A common stock held by Advent International GPE IX-D SCSP; (x) 2,156,723 shares of Class A common stock held by Advent International GPE IX-E SCSP; (xi) 97,427 shares of Class A common stock held by Advent Partners GPE IX Strategic Investors SCSP; (xii) 55,642 shares of Class A common stock held by Advent Partners GPE IX Limited Partnership; (xiii) 128,669 shares of Class A common stock held by Advent Partners GPE IX-A Limited Partnership; (xiv) 321,070 shares of Class A common stock held by Advent Partners GPE IX-C Limited Partnership (f/k/a Advent Partners GPE IX Cayman Limited Partnership); (xv) 54,121 shares of Class A common stock held by Advent Partners GPE IX Cayman Limited Partnership; (xvi) 898,507 shares of Class A common stock held by Advent Partners GPE IX-B Cayman Limited Partnership (the funds set forth in the foregoing clauses (i)-(xvi), the "Advent GPE IX Funds"); (xvii) 3,818,770 shares of Class A common stock held by Advent Global Technology Limited Partnership; (xviii) 2,971,879 shares of Class A common stock held by Advent Global Technology-B Limited Partnership; (xix) 1,609,070 shares of Class A common stock held by Advent Global Technology-C Limited Partnership; (xx) 1,926,387 shares of Class A common stock held by Advent Global Technology-D Limited Partnership; (xxi) 1,885,069 shares of Class A common stock held by Advent Global Technology-A SCSP; (xxii) 31,561 shares of Class A common stock held by Advent Partners AGT Limited Partnership; (xxiii) 27,373 shares of Class A common stock held by Advent Partners AGT-A Limited Partnership; (xxiv) 317,329 shares of Class A common stock held by Advent Partners AGT-C Limited Partnership (f/k/a Advent Partners AGT-Cayman Limited Partnership); (xxv) 30,542 shares of Class A common stock held by Advent Global Technology Strategic Investors Limited Partnership (the funds set forth in the following clauses (xvii)-(xxv), the "Advent Global Technology Funds"); and (xxvi) 3,623,787 shares of Class A common stock held by Advent Global Opportunities Master Limited Partnership (f/k/a Sunley House Capital Master Limited Partnership). Advent International GPE IX, LLC indirectly controls the general partner or manager, as applicable, of each of the Advent GPE IX Funds. Advent Global Technology LLC indirectly controls the general partner or manager, as applicable, of each of the Advent Global Technology Funds. Advent Global Opportunities GP LLC and Advent Global Opportunities Management LLC are the general partner and investment manager, respectively, of Advent Global Opportunities Master Limited Partnership. Advent International GP, LLC is the general partner of Advent International, L.P., and Advent International, L.P. is the manager of Advent International GPE IX, LLC and Advent Global Technology LLC, and is the sole member of Advent Global Opportunities GP LLC and Advent Global Opportunities Management LLC. Accordingly, each of Advent International GP, LLC and Advent International, L.P. may be deemed to have voting and dispositive power over the shares directly held by the Advent GPE IX Funds, the Advent Global Technology Funds, and Advent Global Opportunities Master Limited Partnership. Pursuant to Rule 13d-4 of the Act, the Reporting Persons declare that filing this statement shall not be construed as an admission that any of the Reporting Persons are beneficial owners of the reported securities, for the purposes of Section 13(d) and/or Section 13(g) of the Act.
    (b)Percent of class:

    See responses to row 11 on each cover page.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See responses to row 5 on each cover page.

     (ii) Shared power to vote or to direct the vote:

    See responses to row 6 on each cover page.

     (iii) Sole power to dispose or to direct the disposition of:

    See responses to row 7 on each cover page.

     (iv) Shared power to dispose or to direct the disposition of:

    See responses to row 8 on each cover page.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Not Applicable
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Advent International, L.P.
     
    Signature:/s/ Neil Crawford
    Name/Title:Neil Crawford / Vice President of Finance, See Exhibit 99.2
    Date:05/13/2026
     
    Advent International GP, LLC
     
    Signature:/s/ Neil Crawford
    Name/Title:Neil Crawford / Vice President of Finance
    Date:05/13/2026
     
    Advent International GPE IX Limited Partnership
     
    Signature:/s/ Neil Crawford
    Name/Title:Neil Crawford / Vice President of Finance, See Exhibit 99.2
    Date:05/13/2026
     
    Advent International GPE IX-H Limited Partnership
     
    Signature:/s/ Neil Crawford
    Name/Title:Neil Crawford / Vice President of Finance, See Exhibit 99.2
    Date:05/13/2026
    Exhibit Information

    99.1 Joint Filing Agreement, dated May 13, 2026 99.2 Signature Page, dated May 13, 2026

    Get the next $DH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DH

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    1/13/2025$4.00Equal Weight → Underweight
    Barclays
    12/20/2024$5.00Equal-Weight
    Stephens
    9/17/2024$7.00Buy
    BTIG Research
    7/31/2024$7.00 → $5.00Neutral → Underweight
    JP Morgan
    5/8/2024$11.50 → $9.00Overweight → Equal-Weight
    Morgan Stanley
    1/17/2024Buy → Hold
    Needham
    1/5/2024Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $DH
    SEC Filings

    View All

    SEC Form 8-K filed by Definitive Healthcare Corp.

    8-K - Definitive Healthcare Corp. (0001861795) (Filer)

    6/5/26 4:05:17 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Definitive Healthcare Corp.

    SCHEDULE 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

    5/14/26 4:18:37 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-Q filed by Definitive Healthcare Corp.

    10-Q - Definitive Healthcare Corp. (0001861795) (Filer)

    5/7/26 4:23:25 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Heller Casey covered exercise/tax liability with 164,377 shares, decreasing direct ownership by 8% to 1,841,476 units (SEC Form 4) (for tax liability)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    6/3/26 4:05:09 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Coop Kevin covered exercise/tax liability with 66,050 shares, decreasing direct ownership by 1% to 5,012,822 units (SEC Form 4) (tax withholding)

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    6/3/26 4:05:03 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Heller Casey covered exercise/tax liability with 1,469 shares, decreasing direct ownership by 0.07% to 2,005,853 units (SEC Form 4) to satisfy withholding obligation

    4 - Definitive Healthcare Corp. (0001861795) (Issuer)

    5/5/26 4:05:06 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Definitive Healthcare advances data platform and integrations to deliver smarter healthcare insights

    FRAMINGHAM, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH), a provider of healthcare data and analytics, today announced several product enhancements designed to give organizations a clearer view of the healthcare ecosystem and help them act on critical market intelligence faster. These updates include expanded medical claims coverage, a new integration for HubSpot, direct access to HCP data within Salesforce, and new AI search capabilities in key products. Together, they strengthen the company's core data foundation and make insights easier to access in the systems teams use every day, helping customers move faster, focus on the right opportunities, and make mo

    5/21/26 9:05:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for First Quarter 2026

    FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.  First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i

    5/7/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl

    4/23/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    11/12/24 11:54:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Definitive Healthcare Corp.

    SC 13G - Definitive Healthcare Corp. (0001861795) (Subject)

    10/3/24 9:08:57 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Definitive Healthcare Corp. (Amendment)

    SC 13G/A - Definitive Healthcare Corp. (0001861795) (Subject)

    2/14/24 4:00:33 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Leadership Updates

    Live Leadership Updates

    View All

    Definitive Healthcare Appoints Kevin Coop as CEO for Next Phase of Company's Growth

    FRAMINGHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Kevin Coop as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective June 24, 2024. Mr. Coop succeeds Jason Krantz, founder and Executive Chairman, who has been serving as Interim CEO since January 2024. Mr. Krantz will continue to serve on the Board of Directors as Executive Chairman after the CEO transition. "Kevin is an outstanding leader. He has deep, hands-on experience with data-focused businesses and has a

    5/28/24 8:00:00 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Established Executive and Milwaukee Business Leader Jim Emling Joins VBA as Executive Chair of the Board of Directors

    Jim Emling, the CEO of Datassential and former long-time president of Milwaukee-based Zywave, has been appointed Executive Chair of the Board of Directors at VBA, the company announced today. "We are delighted to welcome Jim officially to VBA as the Executive Chair," said Michael Clayton, the company's President and CEO. "Jim and I have worked closely together over the last 3 months and his decades of experience scaling high growth software companies combined with his strong ties to the Milwaukee technology sector will be tremendous assets to VBA as we enter our next phase of growth." Emling has deep roots in the Milwaukee technology community. He was the founding CTO of Zywave and serv

    11/28/23 5:00:00 PM ET
    $DH
    $GDRX
    Computer Software: Prepackaged Software
    Technology
    EDP Services

    Definitive Healthcare Names Carrie Lazorchak as Chief Revenue Officer

    FRAMINGHAM, Mass., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that Carrie Lazorchak has been named Chief Revenue Officer, effective November 1, 2023. "I am thrilled to welcome Carrie Lazorchak to Definitive Healthcare as our new Chief Revenue Officer," said Robert Musslewhite, Chief Executive Officer of Definitive Healthcare. "Carrie is a fantastic fit for Definitive Healthcare. Her values and her deep belief in the power of humble collaboration make her a perfect match for our culture. Carrie brings a wealth of experience selling Software as a Service to both enterprise accounts and

    10/5/23 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Financials

    Live finance-specific insights

    View All

    Definitive Healthcare Reports Financial Results for First Quarter 2026

    FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter ended March 31, 2026.  First Quarter 2026 Financial Highlights: Revenue was $55.9 million, a decrease of 6% from $59.2 million in Q1 2025. Net Loss, inclusive of goodwill impairment charges of $197.2 million, was $(192.4) million, or (344)% of revenue, compared to $(155.1) million in Q1 2025, inclusive of goodwill impairment charges of $176.5 million, or (262)% of revenue. Adjusted Net Income was $8.5 million, compared to $7.0 million i

    5/7/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

    FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results. A live audio webcast of the event will be available on the Definitive Healthcare's Investor Relations website at https://ir.definitivehc.com/. A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortl

    4/23/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2025

    FRAMINGHAM, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare" or the "Company") (NASDAQ:DH), an industry leader in healthcare market data and analytics, today announced financial results for the quarter and full year ended December 31, 2025.  Fourth Quarter 2025 Financial Highlights: Revenue was $61.5 million, a decrease of 1% from $62.3 million in Q4 2024.Net Loss, inclusive of goodwill impairment charges of $19.5 million, was $(17.1) million, or (28)% of revenue, compared to $(84.7) million in Q4 2024, inclusive of goodwill impairment charges of $97.1 million, or (136)% of revenue.Adjusted Net Income was $8.6 million, compared to $12.6 millio

    2/26/26 4:05:00 PM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    $DH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Definitive Healthcare downgraded by BTIG Research

    BTIG Research downgraded Definitive Healthcare from Buy to Neutral

    5/9/25 8:41:31 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Definitive Healthcare downgraded by Barclays with a new price target

    Barclays downgraded Definitive Healthcare from Equal Weight to Underweight and set a new price target of $4.00

    1/13/25 7:41:23 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology

    Stephens initiated coverage on Definitive Healthcare with a new price target

    Stephens initiated coverage of Definitive Healthcare with a rating of Equal-Weight and set a new price target of $5.00

    12/20/24 7:31:03 AM ET
    $DH
    Computer Software: Prepackaged Software
    Technology